Page last updated: 2024-08-24

3-iodobenzylguanidine and Demyelinating Diseases

3-iodobenzylguanidine has been researched along with Demyelinating Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Atak, F; Aydın, GB; Oğuz, KK; Öncel, İ; Öz, S1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Demyelinating Diseases

ArticleYear
Rhombencephalitis and longitudinal extensive myelitis associated with dinutuximab use in high-risk neuroblastoma.
    The Turkish journal of pediatrics, 2023, Volume: 65, Issue:3

    Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Child, Preschool; Demyelinating Diseases; Female; Hematopoietic Stem Cell Transplantation; Humans; Myelitis; Neuroblastoma; Transplantation, Autologous

2023